The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal.

Elisabeth Moss is leading a rebellion in the sixth and final season "The Handmaid's Tale," which arrives on Hulu April 8.

Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...

Nvidia stock rises after the chip maker makes a number of product announcements at its annual AI GTC conference, Tesla trades ...

The sixth and final season of the award-winning Hulu drama will be a “love letter” to fans who’ve stuck with it through five ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

The official trailer for The Handmaid's Tale's final season shows June (Elisabeth Moss) returning to Gilead amid a revolution ...

Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is ...

Gilead Sciences (GILD) stock fell after The Wall Street Journal reported that the Health and Human Services Department is looking at ...

We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are ...

As The Handmaid's Tale Season 6 approaches, netizens are making predictions about how the last season will wrap up the story.